Import for export guidance
This article was originally published in The Rose Sheet
Cosmetics and color additives "intended for processing into a cosmetic product" do not meet the requirements for "import for export" and such requests for import should be refused entry, FDA states. Agency released 1guidance on "import for export" regulatory procedures Sept. 13 to assist field offices in handling products intended for import into the U.S. Color additives not intended for cosmetic processing, along with dietary supplement, food additives, drugs and devices can be imported for export, but must be further processed into a product that will be exported from the U.S., FDA says. Guidance is effective immediately based on Bioterrorism Act, but FDA will accept comments and revise as appropriate, agency says...
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.